Stanford has a campus-wide site license for Reaxys Xcelerate. Beginning September 1, 2019, we also have access to Reaxys Medicinal Chemistry (RMC) which is integrated into the Reaxys interface.
Beginning September 1, 2022, we also have access to Reaxys Predictive Retrosynthesis.
Four sessions were held: (1) searching organic structures and reactions, (2) searching inorganic and organometallic substances, (3) searching bioactive and medicinal compounds, and (4) searching patents.
About
Reaxys enables researchers to:
Discover chemical structures, properties and reactions
Find relevant literature and patents with ease
Assess compound synthesis and purchase options
Reaxys Medicinal Chemistry empowers hit identification and lead optimization with:
Normalized substance–target affinity data
Comprehensive pharmacokinetic, efficacy, toxicity, safety and metabolic profiles
Data from in vivo animal studies
Tools for hit set assessment, including an interactive heatmap and bioactivity tables